Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclin dependent kinase inhibitors

J W Harper1

  • 1Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030, USA.

Cancer Surveys
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Cyclin-dependent kinase inhibitors (CKIs) regulate cell cycle progression in mammals. While not essential for survival, CKI loss impacts cell cycle control, development, and tumor suppression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cells.

Scientific reports·2019
Same author

RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathway.

Science advances·2019
Same author

Co-morbid diabetes in patients with Crohn's disease predicts a greater need for surgical intervention.

Alimentary pharmacology & therapeutics·2011
Same author

High-pressure processing of Turkish white cheese for microbial inactivation.

Journal of food protection·2008
Same author

Cyclin-dependent kinases.

Chemical reviews·2001
Same author

Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.

Science (New York, N.Y.)·2001
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Eukaryotic cell cycle progression is controlled by cyclin-dependent kinases (CDKs).
  • CDKs are negatively regulated by phosphorylation and cyclin kinase inhibitors (CKIs).
  • Two mammalian CKI classes exist: INK4 and CIP/KIP.

Purpose of the Study:

  • To summarize the current understanding of CKIs' roles in cell growth control.
  • To highlight the versatility of CKIs as negative regulators of CDK function.
  • To discuss the potential involvement of CKIs in development, checkpoint control, and tumor suppression.

Main Methods:

  • Analysis of CKI knockout phenotypes in mammalian cells.

Main Results:

Related Experiment Videos

  • CKI knockout mice generally survive.
  • Observed phenotypes in knockout models reflect the loss of cell cycle inhibition.
  • CKIs play versatile roles in regulating CDK activity.

    • Conclusions:

    • CKIs are crucial negative regulators of the cell cycle.
    • Loss of CKIs leads to observable phenotypes related to cell cycle control.
    • CKIs have significant implications in development, checkpoint control, and tumor suppression.